ESR1 and rheumatoid arthritis: The clinical analysis showed that only RA patients in the low tmTNF RSA group responded with a significant decrease of CRP (Figure 5A) and ESR (Figure 5B) during the initial 12 weeks of therapeutic TNF blockade, whereas the high tmTNF RSA group did not.